Email this article to a friend
Drotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysis
-
* Corresponding author: James M Brophy james.brophy@mcgill.ca
BMC Anesthesiology 2007, 7:5 doi:10.1186/1471-2253-7-5